A broad cytotoxic T lymphocyte response to influenza type B virus presented by multiple HLA molecules

International Immunology

Volumn 9, Issue 6, 1997, Pages 815-823

  Robbins, Penelope A ^a   Rota, Paul A ^b   Shapiro, Stuart Z ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

Cytotoxic T lymphocyte; HLA B8; HLA DR1; Influenza B virus; Peptides

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA B7 ANTIGEN; HLA B8 ANTIGEN; HLA DR1 ANTIGEN; HLA DR3 ANTIGEN;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; HUMAN CELL; INFLUENZA VIRUS B; NORMAL HUMAN; PRIORITY JOURNAL;

ANTIGEN PRESENTATION; CONSERVED SEQUENCE; EPITOPE MAPPING; EPITOPES, T-LYMPHOCYTE; HLA ANTIGENS; HLA-A1 ANTIGEN; HLA-A2 ANTIGEN; HLA-B7 ANTIGEN; HLA-B8 ANTIGEN; HLA-C ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFLUENZA B VIRUS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030907678     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/9.6.815     Document Type: Article

References (57)

1. Center for Disease Control. 1995. Update: influenza activity - United States and worldwide, 1994-95 season, and composition of the 1995-96 influenza vaccine. J. Am. Med. Ass. 273:1565.
2. Center for Disease Control. 1986. Influenza-United States, 1985-1986 season. Morb. Mortal. Wkly Rep. 25:475.
3. Center for Disease Control. 1991 Update: influenza activity - United States and worldwide, and the composition of the 91-92 influenza vaccine. Morb. Mortal. Wkly Rep. 40:231.
4. Center for Disease Control. 1992. Update: influenza activity - United States and worldwide, and composition of the 1992-93 influenza vaccine. Morb. Mortal. Wkly Rep. 41:315.
5. Chapman, L. E., Tipple, M. A., Folger, S. G., Harmon, M., Kendel, A. P., Cox, N. J. and Schonberger, L. B. 1993. Influenza - United States, 1988-89. Morb. Mortal Wkly Rep. CDC Surveill Summ. 19:9.
6. Rota, P. A., Hemphill, M. L, Whistler, T., Regnery, H. L and Kendal, A. P. 1992. Antigenic and genetic characterization of the heamagglutinins of recent cocirculating strains of influenza B virus. J. Gen. Virol. 73:2723.
7. Davis, L. E., Blisard, K. S. and Kornfield, M. 1990. The influenza B virus mouse model of Reye's syndrome: clinical, virologie and morphologic studies of the encephalopathy. J. Neurol. Sci. 97:221.
8. Liou, Y. S., Barbour, S. D., Bell, L. M. and Plotkin, S. A. 1987. Children hospitalized with influenza B infection Pediatr. Infect. Dis. J. 6:541.
9. Hawkins, S. A., Lyttle, J. A. and Connolly, J. H. 1987. Two cases of influenza B encephalitis. J. Neurol. Neurosurg. Psychiatry 50:1236
10. Kelly, K. J., Garland, J. S., Tang. T. T, Shug, A. L. and Chusid, M. J. 1989. Fatal rhabdomyolysis following influenza infection in a girl with familial carnitine palmityl transferase deficiency. Pediatrics 84:312.
11. Webster, R. G. and Berton, M. T. 1981. Analysis of antigenic drift in the heamagglutinin molecule of influenza B virus with monoclonal antibodies. J. Gen. Virol. 54:243.
12. Both, G.W., Sleigh, M. J., Cox, N. J. and Kendal, A. P. 1983. Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J. Virol. 48:52.
13. Krystal, M., Young, J. F., Palese, P., Wilson, I. A., Skehel, J. J. and Wiley, D. C, 1983. Sequential mutations in heamagglutinins of influenza B virus isolates: definition of antigenic domains. Proc. Natl Acad. Sci. USA 80:4527.
14. Lu, B. L., Webster, R. G., Brown, L. E. and Nerome, K. 1983. Heterogeneity of influenza B viruses. Bull. WHO 61:681.
15. Oxford, J. S., Klimov, A. I., Corcoran, T., Ghendon, Y. Z. and Schild, G. C. 1984, Biochemical and serological studies of influenza B viruses: comparisons of historical and recent isolates. Virus Res. 1:241.
16. Hovanec, D. L. and Air, G. M. 1984. Antigenic structure of the hemagglutinin of Influenza virus B/Hong Kong 8/73 as determined from gene sequence analysis of variants selected with monoclonal antibodies. Virology 139:384.
17. Rota, P.A., Shaw, M. W. and Kendal, A. P. 1987. Comparison of the immune response to variant influenza type B hemagglutinins expressed in vaccinia virus. Virology 161:269.
18. Rota, P.A., Wallis, T. R., Harmon, M. W., Rota, J. S., Kendal, A. P. and Nerome. K. 1990. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175:59.
19. Kanegae, Y., Sugita, S., Endo, A., Iskida, M., Senya, S., Osako, K., Nerome, K. and Oya, A. 1990. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirulating lineages in the same epidemic season. J. Virol. 64:2860.
20. Townsend, A, R. M., Rothbard, J., Gotch, F. M., Badaher, G., Wraith, D. and McMichael, A. J. 1986. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44:959.
21. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S. Strominger, J. L. and Wiley, D. C. 1987. The foreign antigen binding site and T cell recognition regions of class l histocompatibility antigens. Nature 329:506
22. Phillips, R. E., Rowland-Jones, S., Nixon, D. F, Gotch, F. M., Edwards, J. P., Ogunlesi, J. G., Elvin, J. A., Rothbard, J., Bangham, C. R. M., Rizza, C. R. and McMichael, A. J. 1991. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354:453.
23. Nowak, M. A., May, R. M., Phillips, R. E., Rowland-Jones, S., Lalloo, D, G., McAdam, S., Klenerman, P., Koppe, B., Sigmund, K., Bangham, C. R. M. and McMichael, A. J. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606
24. Nowak, M. A, and Bangham, C. R. M. 1996. Population dynamics of immune responses to persistent viruses. Science 272:74.
25. Robbins, P. A., Lettice, L. A., Rota, P., Santos-Aguado, J., Rothbard, J., McMichael, A. J. and Strominger, J. L. 1989. Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. J. Immunol. 143:4098.
26. Robbins, P. A., Garboczi, D. N. and Strominger, J. L. 1995. HLA-A*0201 complexes with two 10-mer peptides differing at the P2 anchor residue have distinct refolding kinetics. J. Immunol. 154:703.
27. Rota, P. A. 1989. Sequence of a cDNA clone of the nucleoprotein gene of influenza B/Ann Arbor/1/86. Nucleic Acids Res. 17:3595.
28. Briedis, D. J. and Tobin, M. 1984. Influenza B virus genome: complete nucleotide sequence of the influenza B/Lee/40 virus genome RNA segment 5 encoding the nucleoprotein and comparison with the B/singapore/222/79 nucleoprotein. Virology 133:448.
29. Lichtenheld, M. G. and Podack, E. R. 1989. Structure of the human perforin gene: a simple gene organization with interesting potential regulatory sequences. J. Immunol. 143:4267.
30. Riedy, M. C., Timm, E. A., Jr and Steward, C. C. 1995. Quantitative RT-PCR for measuring gene expression. BioTechniques 18:7.
31. Takahashi, T., Tanaka, M., Inazawa, J., Abe, T., Suda, T. and Nagata, S. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567.
32. Townsend, A. R. M. and Skehel, J. J. 1984. The influenza A virus nucleoprotein gene controls the induction of both subtype specific and cross reactive cytotoxic T cells. J. Exp. Med. 160:552.
33. Malcherek, G., Falk, K., Rotzschke, O., Rammensee, H.-G., Stevanovic, V., Gnau, S., Jung, G. and Melms, A. 1993. Natural peptide ligands motifs of two HLA molecules associated with myasthenia gravis. Int. Immunol. 5:1229.
34. Sutton, J., Rowland-Jones, S., Nixon, D., Gotch, F., Gao, X.-M., Murrary, N., Spoonas, A., Driscoll, P., Smith, M., Willis, A. and McMichael, A. J. 1993. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA-B8 revealed by analysis of epitopes and eluted peptides. Eur. J. Immunol. 23:447.
35. Gotch, F. M., Nixon, D. F., Alp, N., McMichael, A. J. and Borysiewicz, L. K. 1990. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int. Immunol. 2:708.
36. Johnson, R. P., Trocha, A., Buchanan, T. M. and Walker, B. D. 1992. Identification of overlapping HLA class I restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoproteins: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med. 175:961.
37. Rotzschke, O. and Falk, K. 1994. Origin, structure and motifs of naturally processed MHC class II ligands. Curr Opin. Immunol. 6:45.
38. Lamb, J. R., Eckels, D. D., Lake, P., Woody, J. N. and Green, N. 1982. Human T-cell clones recognize chemically synthesized peptides of influenza hemagglutinin. Nature 306:67.
39. Hackett, C. J., Horowitz, D., Wysocka, M. and Eisenlohr, L. C. 1991. Immunogenic peptides of influenza virus subtype N1 neuraminidase identify a T-cell determinant used in class II major histocompatibility complex-restricted responses to infectious virus. J. Virol. 65:672.
40. + T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection, J. Virol. 69:7497.
41. Brown, J .H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J, L. and Wiley, D. C. 1993. The three-dimensional structure of the human class II histocompatibility antigen HLA-DR. Nature 364:33.
42. Stern, L. J., Brown, J. H., Jardetsky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215.
43. Bootman, J. S. and Robertson, J. S. 1988. Sequence analysis of the hemagglutinin of B/Ann Arbor/1/86, an epidemiologically significant variant of influenza B virus. Virology 166:271.
44. - cytotoxic T cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T cell clones. J. Virol. 63:1823.
45. McMichael, A. and Askonas, B. 1978. Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell. Eur. J. Immunol. 8:708.
46. Biddison, W. E., Shaw, S. and Nelson, D. C. 1979. Virus specificity of human influenza virus-immune cytotoxic T cells. J. Immunol. 122:660.
47. Kaplan, D. R., Griffith, R., Braciale, V. L. and Braciale, T. J. 1984. Influenza virus-specific human cytotoxic T cell clones: heterogeneity in antigenic specificity and restriction by class II MHC products. Cell. Immunol. 88:193.
48. Liu, C.-C., Walsh, C. M. and Ding-E Young, J. 1995. Perforin: structure and function, Immunol. Today 16:194.
49. Takayama, H., Shinohara, N., Kawasaki, A., Someya, Y, Hanaoka, S., Kojima, H., Yagita, H., Okumura, K. and Shinkai, Y-I. 1991. Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones. Int. Immunol. 3:1149.
50. Lancki, D. W., Hsieh, C.-R. and Fitch, F. W. 1991. Mechanisms of lysis by cytotoxic T lymphocytes clones. J. Immunol. 146:3242.
51. Nakata, M., Kawasaki, A., Azuman, M., Tsuji, K., Matsuda, H., Shinkkai, Y, Yagita, H, and Okumura, K. 1992. Expression of perforin and cytolytic potential of human peripheral blood lymphocyte subpopulations. Int. Immunol. 4:1049.
52. Ju, S. T., Cui, H., Panka, D. J., Ettinger, R. and Marshak-Rothstein, A. 1994. Participation of target fas protein in apoptosis pathway induced by CD4 TH1 and CD8 cytotoxic T cells. Proc. Natl Acad. Sci. USA 91:4185.
53. Nagata, S. and Goldstein, P, 1995. The Fas death factor. Science 267:1449.
54. + phenotype. J. Immunol. 146:257.
55. + cytotoxic T cell precursors. Clin. Exp. Immunol. 93:363.
56. Fung-Leung, W. P., Kundig, T. M., Zinkernagel, R. M. and Mak, T. W. 1991. Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression. J. Exp. Med. 174:1425.
57. Muller, D., Soller, B. H., Whitton, J. L., LaPan, K.E., Brigman, K. K. and Frelinger, J. A. 1992. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice. Science 20:1576